JP2010505591A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010505591A5 JP2010505591A5 JP2009532357A JP2009532357A JP2010505591A5 JP 2010505591 A5 JP2010505591 A5 JP 2010505591A5 JP 2009532357 A JP2009532357 A JP 2009532357A JP 2009532357 A JP2009532357 A JP 2009532357A JP 2010505591 A5 JP2010505591 A5 JP 2010505591A5
- Authority
- JP
- Japan
- Prior art keywords
- medical device
- implantable
- insertable medical
- porous region
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 9
- 239000011148 porous material Substances 0.000 claims 6
- 239000000758 substrate Substances 0.000 claims 6
- 229940124597 therapeutic agent Drugs 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 229910052751 metal Inorganic materials 0.000 claims 3
- 239000002184 metal Substances 0.000 claims 3
- 229920000642 polymer Chemical group 0.000 claims 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical group [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 2
- 239000003146 anticoagulant agent Substances 0.000 claims 2
- 239000000919 ceramic Substances 0.000 claims 2
- 210000005167 vascular cell Anatomy 0.000 claims 2
- 239000004593 Epoxy Substances 0.000 claims 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical group [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
- 229940035674 anesthetics Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 230000002095 anti-migrative effect Effects 0.000 claims 1
- 230000001028 anti-proliverative effect Effects 0.000 claims 1
- 229940127219 anticoagulant drug Drugs 0.000 claims 1
- 239000003080 antimitotic agent Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 229960004676 antithrombotic agent Drugs 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 229920006037 cross link polymer Polymers 0.000 claims 1
- 230000003028 elevating effect Effects 0.000 claims 1
- 230000010102 embolization Effects 0.000 claims 1
- 210000003238 esophagus Anatomy 0.000 claims 1
- 210000002744 extracellular matrix Anatomy 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 239000003193 general anesthetic agent Substances 0.000 claims 1
- 239000003966 growth inhibitor Substances 0.000 claims 1
- 239000007952 growth promoter Substances 0.000 claims 1
- 210000002216 heart Anatomy 0.000 claims 1
- 210000003709 heart valve Anatomy 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000002107 myocardial effect Effects 0.000 claims 1
- 229910052759 nickel Inorganic materials 0.000 claims 1
- 230000008520 organization Effects 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 229920000307 polymer substrate Polymers 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 239000011343 solid material Substances 0.000 claims 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 claims 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 239000010936 titanium Chemical group 0.000 claims 1
- 229910052719 titanium Chemical group 0.000 claims 1
- 210000003437 trachea Anatomy 0.000 claims 1
- 210000002229 urogenital system Anatomy 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 210000005166 vasculature Anatomy 0.000 claims 1
- 229940124549 vasodilator Drugs 0.000 claims 1
- 239000003071 vasodilator agent Substances 0.000 claims 1
- 230000002861 ventricular Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/545,439 US7666179B2 (en) | 2006-10-10 | 2006-10-10 | Medical devices having porous regions for controlled therapeutic agent exposure or delivery |
| PCT/US2007/021055 WO2008045228A2 (en) | 2006-10-10 | 2007-10-01 | Medical devices having porous regions for controlled therapeutic agent exposure or delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010505591A JP2010505591A (ja) | 2010-02-25 |
| JP2010505591A5 true JP2010505591A5 (enExample) | 2010-11-25 |
Family
ID=39091787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009532357A Pending JP2010505591A (ja) | 2006-10-10 | 2007-10-01 | 制御された治療薬の曝露または放出のための多孔質領域を有する医療デバイス |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7666179B2 (enExample) |
| EP (1) | EP2089070B1 (enExample) |
| JP (1) | JP2010505591A (enExample) |
| AT (1) | ATE554800T1 (enExample) |
| CA (1) | CA2669075A1 (enExample) |
| WO (1) | WO2008045228A2 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7445616B2 (en) * | 2001-03-23 | 2008-11-04 | Petrakis Dennis N | Temperature responsive systems |
| US8172458B2 (en) * | 2001-03-23 | 2012-05-08 | Petrakis Dennis N | Temperature responsive systems |
| US20050182443A1 (en) | 2004-02-18 | 2005-08-18 | Closure Medical Corporation | Adhesive-containing wound closure device and method |
| US20060009099A1 (en) | 2004-07-12 | 2006-01-12 | Closure Medical Corporation | Adhesive-containing wound closure device and method |
| NZ588816A (en) | 2007-01-21 | 2011-11-25 | Hemoteq Ag | Medical device for the treatment of stenoses of corporal lumina and for the prevention of impending restenoses |
| US8187255B2 (en) * | 2007-02-02 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
| WO2009006390A2 (en) | 2007-07-03 | 2009-01-08 | Charles Stark Draper Laboratory, Inc. | Drug-eluting staples prosthesis |
| US9192697B2 (en) | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
| US7833266B2 (en) * | 2007-11-28 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
| GB0811874D0 (en) * | 2008-06-30 | 2008-07-30 | Nemaura Pharma Ltd | Patches for reverse iontophoresis |
| US20110159070A1 (en) * | 2008-07-03 | 2011-06-30 | The Regents Of The University Of California | Biomaterials and implants for enhanced cartilage formation, and methods for making and using them |
| US7951193B2 (en) * | 2008-07-23 | 2011-05-31 | Boston Scientific Scimed, Inc. | Drug-eluting stent |
| US7727450B1 (en) * | 2009-01-20 | 2010-06-01 | Gm Global Technology Operations, Inc. | Method of using shape memory polymers |
| US10369256B2 (en) | 2009-07-10 | 2019-08-06 | Boston Scientific Scimed, Inc. | Use of nanocrystals for drug delivery from a balloon |
| EP2453938B1 (en) | 2009-07-17 | 2015-08-19 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
| CN102065372B (zh) * | 2009-11-16 | 2014-10-08 | 中国移动通信集团公司 | 以广播方式传输数据的方法及相关装置 |
| US8992411B2 (en) | 2010-02-16 | 2015-03-31 | Ams Research Corporation | Bioabsorbable mesh for surgical implants |
| US8889211B2 (en) | 2010-09-02 | 2014-11-18 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
| JP5696279B2 (ja) * | 2010-12-01 | 2015-04-08 | 学校法人自治医科大学 | 長期徐放型薬剤硬膜外腔留置システム |
| AU2012220537A1 (en) * | 2011-02-23 | 2013-08-29 | Ams Research Corporation | Pelvic implant and therapeutic agent system and method |
| US8669360B2 (en) | 2011-08-05 | 2014-03-11 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
| WO2013028208A1 (en) | 2011-08-25 | 2013-02-28 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
| FR2986156B1 (fr) * | 2012-01-30 | 2014-07-04 | Rhenovia Pharma | Dispositif transdermique pour l'administration controlee a un patient d'au moins un principe actif |
| US11013835B2 (en) | 2012-02-03 | 2021-05-25 | Board Of Regents, The University Of Texas System | Processability of polymeric substrates and related methods |
| US9526640B2 (en) | 2013-08-18 | 2016-12-27 | Boston Scientific Scimed, Inc. | Anti-migration micropatterned stent coating |
| DE102012025143A1 (de) * | 2012-11-07 | 2014-05-08 | Heraeus Medical Gmbh | Verfahren zur Wirkstofffreisetzung und Wirkstofffreisetzungssysteme |
| US20150336058A1 (en) * | 2013-01-31 | 2015-11-26 | Regents Of The University Of Minnesota | Nanoporous filtration membranes |
| EP2849212B1 (en) * | 2013-09-17 | 2018-05-23 | IMEC vzw | Protection of porous substrates before treatment |
| US20150342760A1 (en) * | 2014-06-02 | 2015-12-03 | Boston Scientific Scimed Inc. | Anti-migration stent |
| CN104803348A (zh) * | 2015-04-20 | 2015-07-29 | 中国科学院光电技术研究所 | 一种牺牲模板制备高深宽比聚合物纳米柱阵列的方法 |
| US10232154B2 (en) * | 2015-07-28 | 2019-03-19 | Boston Scientific Scimed, Inc. | Implantable medical devices and related methods of use |
| EP3481571A4 (en) * | 2016-07-05 | 2020-07-22 | Porosteon Development LLC | POROUS METAL DEVICES |
| US10792024B2 (en) | 2016-09-28 | 2020-10-06 | Ethicon, Inc. | Scaffolds with channels for joining layers of tissue at discrete points |
| USD848624S1 (en) | 2016-09-29 | 2019-05-14 | Ethicon, Inc. | Release paper for wound treatment devices |
| US10687986B2 (en) | 2016-09-29 | 2020-06-23 | Ethicon, Inc. | Methods and devices for skin closure |
| US10470935B2 (en) | 2017-03-23 | 2019-11-12 | Ethicon, Inc. | Skin closure systems and devices of improved flexibility and stretchability for bendable joints |
| US20180271505A1 (en) * | 2017-03-23 | 2018-09-27 | Ethicon, Inc. | Scaffolds for Joining Layers of Tissue at Discrete Points |
| US11504446B2 (en) | 2017-04-25 | 2022-11-22 | Ethicon, Inc. | Skin closure devices with self-forming exudate drainage channels |
| US10993708B2 (en) | 2018-07-31 | 2021-05-04 | Ethicon, Inc. | Skin closure devices with interrupted closure |
| WO2020207793A1 (en) * | 2019-04-08 | 2020-10-15 | Universite De Lille | Cutaneous device for storing and releasing molecules, and corresponding method |
| WO2020226983A1 (en) * | 2019-05-03 | 2020-11-12 | Monroe Mary Beth | Shape memory polymer hydrogels for wound healing |
| US11707351B2 (en) | 2019-08-19 | 2023-07-25 | Encompass Technologies, Inc. | Embolic protection and access system |
| JP7508551B2 (ja) | 2019-10-29 | 2024-07-01 | ボストン サイエンティフィック サイムド，インコーポレイテッド | ずれ防止機能を有するステント |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8527369D0 (en) * | 1985-11-06 | 1985-12-11 | Smiths Industries Plc | Catheters |
| JPH01285274A (ja) * | 1988-05-12 | 1989-11-16 | Olympus Optical Co Ltd | 薬剤徐放装置 |
| JPH0723572B2 (ja) | 1988-10-17 | 1995-03-15 | 三菱重工業株式会社 | 形状記憶性ポリマーによる織布 |
| US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6106642A (en) | 1998-02-19 | 2000-08-22 | Boston Scientific Limited | Process for the improved ductility of nitinol |
| IL144948A0 (en) * | 1999-02-18 | 2002-06-30 | Biovalve Technologies Inc | Electroactive pore |
| US6491061B1 (en) | 2000-02-25 | 2002-12-10 | University Of New Mexico | Stimuli responsive hybrid materials containing molecular actuators and their applications |
| US6682521B2 (en) | 2000-03-23 | 2004-01-27 | Dennis N. Petrakis | Temperature activated systems |
| EP1372602B1 (en) * | 2001-01-09 | 2007-04-18 | Microchips, Inc. | Flexible microchip devices for ophthalmic and other applications |
| US20030109824A1 (en) | 2001-11-07 | 2003-06-12 | Microvena Corporation | Distal protection device with local drug delivery to maintain patency |
| US7108685B2 (en) * | 2002-04-15 | 2006-09-19 | Boston Scientific Scimed, Inc. | Patch stabilization of rods for treatment of cardiac muscle |
| US20040193262A1 (en) * | 2003-03-29 | 2004-09-30 | Shadduck John H. | Implants for treating ocular hypertension, methods of use and methods of fabrication |
| US20050013988A1 (en) | 2003-04-16 | 2005-01-20 | Qiang Fu | Stimuli responsive mesoporous materials for control of molecular transport |
| US7356368B2 (en) * | 2004-07-21 | 2008-04-08 | Boston Scientific Scimed, Inc. | Light-activated anti-infective coatings and devices made thereof |
| JP2005139183A (ja) * | 2004-11-04 | 2005-06-02 | Cellseed Inc | 刺激応答性材料の利用方法 |
| US20060127442A1 (en) | 2004-12-09 | 2006-06-15 | Helmus Michael N | Use of supercritical fluids to incorporate biologically active agents into nanoporous medical articles |
| US20060129215A1 (en) * | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery |
| US20070148251A1 (en) * | 2005-12-22 | 2007-06-28 | Hossainy Syed F A | Nanoparticle releasing medical devices |
| US20070224235A1 (en) | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
-
2006
- 2006-10-10 US US11/545,439 patent/US7666179B2/en not_active Expired - Fee Related
-
2007
- 2007-10-01 AT AT07839083T patent/ATE554800T1/de active
- 2007-10-01 WO PCT/US2007/021055 patent/WO2008045228A2/en not_active Ceased
- 2007-10-01 CA CA002669075A patent/CA2669075A1/en not_active Abandoned
- 2007-10-01 JP JP2009532357A patent/JP2010505591A/ja active Pending
- 2007-10-01 EP EP07839083A patent/EP2089070B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010505591A5 (enExample) | ||
| EP2131882B1 (en) | Medical devices having nanoporous coatings for controlled therapeutic agent delivery | |
| EP2094202B1 (en) | Medical devices having coatings for controlled therapeutic agent delivery | |
| US8388678B2 (en) | Medical devices having porous component for controlled diffusion | |
| US8114148B2 (en) | Medical devices for delivery of therapeutic agent in conjunction with galvanic corrosion | |
| US8734829B2 (en) | Medical devices having polymeric nanoporous coatings for controlled therapeutic agent delivery and a nonpolymeric macroporous protective layer | |
| US8974809B2 (en) | Medical devices having a filter insert for controlled diffusion | |
| EP2175903B1 (en) | Drug eluting medical devices having porous layers | |
| US7666179B2 (en) | Medical devices having porous regions for controlled therapeutic agent exposure or delivery | |
| EP2190493B1 (en) | Medical devices having a metal particulate composition for controlled diffusion | |
| EP2200673B1 (en) | Medical devices having nanofiber-textured surfaces | |
| JP2010518944A5 (enExample) | ||
| US20100028403A1 (en) | Medical devices for therapeutic agent delivery | |
| JP2004520088A (ja) | 薬剤混和マトリックス | |
| EP2010241A2 (en) | Medical devices having nanoporous coatings for controlled therapeutic agent delivery | |
| WO2009039429A2 (en) | Therapeutic agent-eluting medical devices having textured polymeric surfaces | |
| CN101014300A (zh) | 金属药物释放医疗器械及其制造方法 | |
| CN106620897B (zh) | 一种抗再狭窄的管腔内支架材料 | |
| Contreras-García et al. | Biomedical Devices Based on Smart Polymers |